A team of academics and clinicians, led by King’s College London, are developing revolutionary technology to transform the way healthcare professionals can help patients with feelings of paranoia.
In a landmark project, experts from King’s College London, University of Bath and The McPin Foundation are working with healthtech startup Avegen Health to develop and trial a new app that will deliver a therapy called STOP (Successful Treatment Of Paranoia), which uses gamified activities and assessments, delivered weekly over twelve weeks, to give patients the tools to overcome paranoid thoughts.
By
NIHR Maudsley BRC at 11 Apr 2023
In the largest study of its kind, research led by King’s College London has identified some of the elements in our immune response that influence our risk for developing psychosis.
By
NIHR Maudsley BRC at 24 Mar 2023
Researchers from King’s College London and University of Oxford have shown that 18.4 per cent of the general UK population report that certain sounds, such as loud chewing, and repetitive sniffing, cause a significant problem in their lives. The condition is known as misophonia.
By
NIHR Maudsley BRC at 22 Mar 2023
Paola Dazzan, NIHR Maudsley BRC Co-Lead for the Psychosis and Mood Disorders Theme, and Professor of Neurobiology of Psychosis and Vice Dean (International) at Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has been appointed to the National Institute for Health and Care Research (NIHR) College of Senior Investigators for 2023 in the 16th round of the Senior Investigator competition.
By
NIHR Maudsley BRC at 1 Mar 2023
For Mental Health Nurses' Day, we spoke to Kete, a Mental Health Nurse at the King's Clinical Research Facility (CRF) about her role and her experience working on Mental Health Clinical Trials.
By
NIHR Wellcome King's Clinical Research Facility at 21 Feb 2023
